Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 40, 2010 - Issue 9
384
Views
34
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Intestinal absorption mechanisms of ginsenoside Rh2: stereoselectivity and involvement of ABC transporters

, , , , , , & show all
Pages 602-612 | Received 26 Feb 2010, Accepted 01 Jun 2010, Published online: 07 Jul 2010
 

Abstract

  1. This study investigated the absorption mechanism of ginsenoside Rh2 to clarify the reasons for its poor absorption. Transepithelial transport across Caco-2 cell monolayers, cellular uptake, and in situ rat intestinal perfusion were examined.

  2. Cellular uptake of Rh2 was linear from 1 to 50 μM at 4°C, whereas it was saturated when the concentration exceeded 10 μM at 37°C. At 37°C, the uptake at 10 μM was linear in 60 min. Intracellular exposure in 240 min was 2173.70 and 979.38 ng·min/μg for S and R isomers, respectively.

  3. Transepithelial permeability of Rh2 was about 10−8 to 10−7 cm/s. Efflux ratios were above 1.5. Sodium dodecyl sulfate, sodium citrate, and sodium deoxycholate had no effect on Rh2 permeability.

  4. After intestinal perfusion for 3 h, 9.1% of 20(R)-Rh2 and 15.7% of 20(S)-Rh2 were absorbed.

  5. Cyclosporine, quercetin, and probenecid could improve the cellular uptake, absorptive permeability, and intestinal absorption. Carrier-mediated transport was the major absorption mechanism. Rh2 was a substrate of ABC transporters.

  6. The ABC-transporter-mediated efflux and the poor permeability were the major reasons for Rh2 poor absorption.

  7. The stereoselective absorption was significant. R isomer exhibited lower absorption profiles in all the experiments, possibly due to more potent efflux.

Acknowledgements

The first author sincerely acknowledged Ms Lei Cai for the support of the manuscript preparation.

Declaration of interest

This research was supported by the National High Technology Foundation of China (863 Project, No. 2003AA2Z347A), the fund of Jiangsu Key Lab of Drug Metabolism and Pharmacokinetics (No. BM2001201) and the Natural Science Foundation of Jiangsu Province (BK 2005098)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.